Key GazetteEditas Medicine, Inc. (NASDAQ:EDIT) Experiences Light Trading VolumeModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella… Continue reading
Key GazetteEditas Medicine, Inc. (NASDAQ:EDIT) Experiences Light Trading VolumeModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella… Continue reading
Paul Tesar receives 2017 New York Stem Cell Foundation — Robertson Stem Cell PrizeEurekAlert (press release)The New York Stem Cell Foundation (NYSCF) announced today that Paul Tesar, DPhil, is the 2017 recipient of the NYSCF – Robertson Stem Cell Priz… Continue reading
New AtlasAnti-aging stem cell treatment proves successful in early human trialsNew AtlasThe results of two human clinical trials into a stem cell therapy that can reverse symptoms of age-associated frailty have been published, and the indications are t… Continue reading
New AtlasAnti-aging stem cell treatment proves successful in early human trialsNew AtlasThe results of two human clinical trials into a stem cell therapy that can reverse symptoms of age-associated frailty have been published, and the indications are t… Continue reading
WTNH Connecticut News (press release) |
Promising Yale cancer research supported by Stamford based non-profit leading charge in gene therapy studies
WTNH Connecticut News (press release) NEW HAVEN, Conn., (WTNH) — Modifying a patient’s cell to kill cancer has been, from the start, the mission of the Alliance for Cancer Gene Therapy in Stamford. Long before it was embraced by the research community, says CEO John Walter, “Cell and gene … CytoSen Therapeutics Appoints CEO and Scientific Advisory BoardMarkets Insider |